Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be th... Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition. 더 보기
Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones PR Newswire BOSTON, Jan. 13, 2025 -- Initiated dosing in Phase 1 clinical trial cohort evaluating...
Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors PR Newswire BOSTON, Dec. 12, 2024 -- EO-1022 is comprised of...
Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024 PR...
Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference PR Newswire BOSTON, Nov. 26, 2024 BOSTON, Nov. 26, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq:...
Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements PR Newswire BOSTON, Nov. 6, 2024 -- Promising initial Phase 1 data of EO-3021 reported...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0803 | -11.3098591549 | 0.71 | 0.71 | 0.585 | 1786786 | 0.63258564 | CS |
4 | 0.039 | 6.60233621127 | 0.5907 | 0.98 | 0.585 | 5212486 | 0.72794541 | CS |
12 | 0.0397 | 6.72881355932 | 0.59 | 0.98 | 0.5221 | 2095656 | 0.69740751 | CS |
26 | -2.3103 | -78.5816326531 | 2.94 | 3.09 | 0.5 | 1541156 | 0.72263682 | CS |
52 | -2.1503 | -77.3489208633 | 2.78 | 5.8299 | 0.5 | 1241563 | 1.81383828 | CS |
156 | -3.3803 | -84.2967581047 | 4.01 | 5.89 | 0.363 | 904106 | 2.30275231 | CS |
260 | -13.3703 | -95.5021428571 | 14 | 16.22 | 0.363 | 764703 | 2.40440936 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관